May 17, 2020

Telenursing Service DialNurse Promotes Medical Consultations

3 min
Telenursing Service DialNurse Promotes Medical Consultations.jpg
Written by Alyssa Clark Breaking into the telehealth and mhealth market, DialNurse announced the expansion of its services of now offering to include...

Written by Alyssa Clark


Breaking into the telehealth and mhealth market, DialNurse announced the expansion of its services of now offering to include private and public enterprises, in looking for ways to include a new form of medical consultation as a main element of its healthcare benefits to employees. An average return investment from investing in telehealth and mehealth programs has a return on investment percentage of 250-350 percent; as a direct impact from the reduced energy admission and reduced office visit costs according to the Society of Actuaries.

"The overwhelmingly positive feedback we've received from our consumer customers indicated that the time was right to extend the benefits of DialNurse services to the business community," said Gunjan Goel, Co-founder & CEO of DialNurse. "During this critical period of healthcare reform, DialNurse is helping the medical infrastructure in the U.S. by addressing the not so urgent cases, thereby reducing the crowding in emergency rooms and doctor's offices. Businesses using this proven service realize direct savings while providing convenient healthcare options for their employees or constituents."

Speaking both English and Spanish, DialNurse utilizes registered and licensed nurses to provide 24/7 care and medical consultations for patients for less than the price of an average co-pay.  DialNurse’s services benefit a range of patients need from: those with high deductible plans, have no medical insurance, are living in remote areas of U.S., or those who simply want medical consultations anonymously. Based out of the U.S., DialNurse has serviced over 5,000,000 calls and has over 12 years experience in the telehealth and mhealth industry.

"DialNurse plays a critical role in solving challenges our members face as they implement healthcare reform," said Todd Sanders, president & CEO of the Greater Phoenix Chamber of Commerce. "We're honored to have DialNurse as a new premier member and look forward to helping it keep the community informed on solutions to the rising costs of healthcare."

DialNurse joined the Greater Phoenix Chamber of Commerce as a premier member in order to broaden its reach and connections within the business community. This connection now enables DialNurse to educate members on the benefits of telenursing and will evolve to an important resource for issues concerning the impact of technology within the healthcare industry. This will increase the backing of DialNurse by having the support of such a well-respected, collaborative and influential state member.

About DialNurse

DialNurse is an on-demand telehealth and mhealth service that provides medical consultation from U.S. based licensed and registered nurses 24x7x365 anywhere, anytime in 43 states. Services can be accessed through the phone, web, or the company's mobile applications on the app stores. For more information, please visit



About the Author

Alyssa Clark is the Editor of Healthcare Global

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article